A novel protein B2URF3 from Akkermansia muciniphila increased by intermittent fasting alleviates vascular

Shi-Yu Zeng1,2, Jiang-Hua Liu3, Ying-Ying Xiang1

  • 1Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.

PubMed

Insights

Alternate-day intermittent fasting (IF1:1) reduces vascular calcification in mice by enhancing gut bacteria, particularly Akkermansia muciniphila. This effect involves Akk-derived extracellular vesicles carrying the protein B2URF3, offering potential therapeutic targets.

Area of Science:

  • Cardiovascular Research
  • Microbiome Science
  • Metabolic Disease

Background:

  • Vascular calcification (VC) significantly increases cardiovascular disease risk, with limited effective treatments.
  • The gut microbiome's role in systemic health, including vascular function, is increasingly recognized.

Purpose of the Study:

  • To investigate the efficacy of intermittent fasting (IF) regimens in preventing vitamin D-induced VC.
  • To elucidate the role of gut microbiota and their derived extracellular vesicles (EVs) in mediating the protective effects of IF against VC.
  • To identify specific molecular mechanisms and potential biomarkers involved in the gut-vascular axis.

Main Methods:

  • Utilized a mouse model of vitamin D-induced VC to compare alternate-day (IF1:1) and 5:2 IF regimens.
  • Assessed the impact of IF on gut microbiota composition, focusing on Akkermansia muciniphila (Akk).
  • Investigated the function of Akk-derived EVs (Akk-EVs) in vascular smooth muscle cells (VSMCs) in vitro and in vivo.
  • Performed proteomic analysis to identify key proteins within Akk-EVs and Akk, and validated interactions with host proteins.
  • Analyzed fecal and serum samples from patients with coronary calcification to correlate findings with clinical observations.

Main Results:

  • Alternate-day intermittent fasting (IF1:1) significantly attenuated vitamin D-induced VC in mice, while a 5:2 IF regimen was ineffective.
  • The protective effect of IF1:1 was dependent on gut microbiota, specifically an enrichment of Akkermansia muciniphila (Akk).
  • Akk-EVs were internalized by VSMCs, suppressing osteogenic differentiation and calcification.
  • The protein B2URF3, highly abundant in Akk-EVs and Akk, was identified as a key mediator, interacting with ALDH1B1 to inhibit VSMC osteogenic transdifferentiation.
  • Reduced fecal Akk abundance and lower serum B2URF3 levels were observed in patients with coronary calcification.

Conclusions:

  • Alternate-day intermittent fasting establishes a gut-vascular axis that mitigates vascular calcification.
  • Akkermansia muciniphila and its derived extracellular vesicles (Akk-EVs) play a crucial role in this protective mechanism.
  • The Akk-EV protein B2URF3 is a critical mediator inhibiting VSMC osteogenic differentiation and represents a potential therapeutic target and biomarker for vascular calcification.

Related Concept Videos

Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...